Raltegravir

HIV/AIDS

Raltegravir

Registration certificate:

INN:

Raltegravir

Release form:

Film-coated tablets

Therapeutic Area:

HIV/AIDS

Pharmacotherapeutic Group:

Antiviral agents for systemic use, Direct-acting antivirals, Integrase inhibitors

Conditions for dispensing:

On prescription

Packaging:

Indications for Use:

Raltegravir is used in combination with other antiretroviral medications for the treatment of HIV-1 infection in:

Children aged 2–11 years (chewable form)
Adults, children, and adolescents aged 6 years and older and weighing at least 25 kg (swallowable form)

This medication is included in the List of Essential Medicines.